Vireo to to seek FDA approval for nonsmokeable cannabis

Publisher： John Wiley & Sons Inc

E-ISSN： 1556-7591|27|47|4-5

ISSN： 1042-1394

Source： ALCOHOLISM AND DRUG ABUSE WEEKLY, Vol.27, Iss.47, 2015-12, pp. : 4-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ticagrelor FDA Approval Issues Revisited

By  

Cardiology, Vol. 122, Iss. 3, 2012-07 ,pp. : 144-147

Karger

Access to resources Recommend Favorite

Sunscreen slow down: The US FDA's sluggish approval of new sunscreens frustrates physicians, manufacturers, and consumers

By  

CANCER, Vol. 121, Iss. 17, 2015-09 ,pp. : 2861-2862

John Wiley & Sons Inc

Access to resources Recommend Favorite

Failure rate: Why many cancer drugs don't receive FDA approval, and what can be done about it

By  

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1529-1530

John Wiley & Sons Inc

Access to resources Recommend Favorite

Availability and approval of cannabis‐based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 22, Iss. 3, 2018-03 ,pp. : 440-454

John Wiley & Sons Inc

Access to resources Recommend Favorite

Advertising Approval

By  

Community Practitioner, Vol. 79, Iss. 9, 2006-09 ,pp. : 281-282

Community Practitioner

Access to resources Recommend Favorite